Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : HELIX BIOPHARMA (HBP:TSE) -- Ignore unavailable to you. Want to Upgrade?

To: trustmanic who wrote (134)	12/1/1997 2:13:00 AM
From: burner	Respond to of 193

George, No I didn't read the article. Let's hope you are right. Dan

To: trustmanic who wrote (134)	12/8/1997 11:53:00 PM
From: burner	Read Replies (1) \| Respond to of 193

Laboratory and diagnostic distribution division closed Helix Biopharma Corp HBP Shares issued 13,743,415 Dec 3 close $0.40 Thu 4 Dec 97 News Release Mr Terrance Owen reports The company has closed its laboratory and diagnostic distribution division. The need of the company to focus its attention upon the profitable core business of DNA testing and the potential of pharmaceuticals, combined with the additional time demands involved in the continued research, development, and testing of new higher margin products and services, was paramount in reaching this decision. After analyzing the external factors of government funding reductions, the weakness of the Canadian dollar and the recent decisions by two of the division's largest suppliers to sell directly into Canada from the US, the board resolved that this division did not warrant the level of resources being applied. The closure of this division will result in a one time charge of approximately $1.8 million. (c) Copyright 1997 Canjex Publishing Ltd. canada-stockwatch.com